معرفی
Dr. Rosalie Heilig is a Research Fellow at the University of Glasgow's School of Cancer Sciences, working within the Institute of Cancer Sciences in Professor Stephen Tait's laboratory (G61 2BD). Her research centers on mitochondrial mechanisms in cancer biology, specifically investigating how mitochondrial dynamics, DNA integrity, and membrane function regulate cell death pathways and inflammatory responses.
Her primary research interests focus on mitochondrial biology's intersection with oncology, including mitochondrial outer membrane permeability, ubiquitin-dependent signaling, NF-κB-mediated inflammation, and caspase-regulated DNA damage. She explores how these processes influence genome stability, tumor microenvironment interactions, and therapeutic resistance in cancer models.
Analysis of her 2022-2024 publications reveals consistent investigation of mitochondrial regulation in inflammatory signaling and genomic integrity, with strong emphasis on translational applications in cancer therapy. Her work bridges molecular cell biology and immunology, highlighting mitochondria as central hubs for stress response coordination in malignant cells.
Dr. Heilig operates within Prof. Tait's research team at the Institute of Cancer Sciences, utilizing advanced cell biology and molecular techniques to dissect mitochondrial contributions to cancer pathogenesis. The lab maintains strong focus on identifying novel therapeutic targets through mechanistic studies of cell death pathways.
